Business Description
Neurocrine Biosciences Inc
NAICS : 325414
SIC : 2836
ISIN : US64125C1099
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.37 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | 1.03 | |||||
Interest Coverage | 98 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 9.05 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.4 | |||||
3-Year EBITDA Growth Rate | 32.8 | |||||
3-Year EPS without NRI Growth Rate | -11.5 | |||||
3-Year FCF Growth Rate | 17.2 | |||||
3-Year Book Growth Rate | 23.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 59 | |||||
Future 3-5Y Total Revenue Growth Rate | 16.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.55 | |||||
9-Day RSI | 44.16 | |||||
14-Day RSI | 46.92 | |||||
6-1 Month Momentum % | 22.17 | |||||
12-1 Month Momentum % | 42.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.52 | |||||
Quick Ratio | 2.47 | |||||
Cash Ratio | 1.7 | |||||
Days Inventory | 319.54 | |||||
Days Sales Outstanding | 76.87 | |||||
Days Payable | 911.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -0.78 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.05 | |||||
Operating Margin % | 23.73 | |||||
Net Margin % | 18.65 | |||||
FCF Margin % | 31.06 | |||||
ROE % | 18.2 | |||||
ROA % | 12.71 | |||||
ROIC % | 22.75 | |||||
ROC (Joel Greenblatt) % | 139.27 | |||||
ROCE % | 20.59 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 38.15 | |||||
Forward PE Ratio | 27.7 | |||||
PE Ratio without NRI | 33.83 | |||||
Shiller PE Ratio | 297.52 | |||||
Price-to-Owner-Earnings | 36.81 | |||||
PEG Ratio | 0.84 | |||||
PS Ratio | 7.11 | |||||
PB Ratio | 5.84 | |||||
Price-to-Tangible-Book | 5.92 | |||||
Price-to-Free-Cash-Flow | 22.88 | |||||
Price-to-Operating-Cash-Flow | 21.79 | |||||
EV-to-EBIT | 27.89 | |||||
EV-to-Forward-EBIT | 20.22 | |||||
EV-to-EBITDA | 26.62 | |||||
EV-to-Forward-EBITDA | 20.88 | |||||
EV-to-Revenue | 6.68 | |||||
EV-to-Forward-Revenue | 5.96 | |||||
EV-to-FCF | 21.55 | |||||
Price-to-Projected-FCF | 2.66 | |||||
Price-to-Graham-Number | 2.98 | |||||
Price-to-Net-Current-Asset-Value | 19.53 | |||||
Price-to-Net-Cash | 111.81 | |||||
Earnings Yield (Greenblatt) % | 3.59 | |||||
FCF Yield % | 4.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Neurocrine Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1,831.732 | ||
EPS (TTM) (€) | 3.351 | ||
Beta | 0.4 | ||
Volatility % | 22.75 | ||
14-Day RSI | 46.92 | ||
14-Day ATR (€) | 3.735897 | ||
20-Day SMA (€) | 127.7975 | ||
12-1 Month Momentum % | 42.91 | ||
52-Week Range (€) | 83.2 - 139.4 | ||
Shares Outstanding (Mil) | 100.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Neurocrine Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Neurocrine Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Neurocrine Biosciences Inc Frequently Asked Questions
What is Neurocrine Biosciences Inc(STU:NB3)'s stock price today?
When is next earnings date of Neurocrine Biosciences Inc(STU:NB3)?
Does Neurocrine Biosciences Inc(STU:NB3) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |